Innophos Holdings Inc (NASDAQ:IPHS) Institutional Investors Sentiment Index Improved in 2018 Q2

Sentiment for Innophos Holdings Inc (NASDAQ:IPHS)

Innophos Holdings Inc (NASDAQ:IPHS) institutional sentiment increased to 1.05 in 2018 Q2. Its up 0.08, from 0.97 in 2018Q1. The ratio improved, as 68 institutional investors increased or started new stock positions, while 65 cut down and sold equity positions in Innophos Holdings Inc. The institutional investors in our partner’s database now have: 18.40 million shares, up from 18.30 million shares in 2018Q1. Also, the number of institutional investors holding Innophos Holdings Inc in their top 10 stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 10 Reduced: 55 Increased: 43 New Position: 25.

Innophos Holdings, Inc., through its subsidiaries, produces performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care, and industrial end markets. The company has market cap of $500.35 million. It operates through Food, Health & Nutrition, Industrial Specialties, and Other divisions. It has a 25.42 P/E ratio. The companyÂ’s specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture additives in cheeses; leavening agents in baked goods; mineral and botanical sources for nutritional supplements; pharmaceutical excipients; and abrasives in toothpaste, as well as in industrial applications, such as asphalt modification and petrochemical catalysis.

The stock decreased 6.73% or $1.84 during the last trading session, reaching $25.52. About 144,805 shares traded or 12.83% up from the average. Innophos Holdings, Inc. (NASDAQ:IPHS) has declined 4.40% since December 6, 2017 and is downtrending. It has underperformed by 20.02% the S&P500.

Analysts await Innophos Holdings, Inc. (NASDAQ:IPHS) to report earnings on February, 20. They expect $0.51 EPS, down 1.92 % or $0.01 from last year’s $0.52 per share. IPHS’s profit will be $10.00 million for 12.51 P/E if the $0.51 EPS becomes a reality. After $0.58 actual EPS reported by Innophos Holdings, Inc. for the previous quarter, Wall Street now forecasts -12.07 % negative EPS growth.

Frontfour Capital Group Llc holds 2.19% of its portfolio in Innophos Holdings, Inc. for 184,724 shares. Ironwood Investment Management Llc owns 35,725 shares or 1.21% of their US portfolio. Moreover, Investment Counselors Of Maryland Llc has 1.05% invested in the company for 471,896 shares. The Illinois-based Segall Bryant & Hamill Llc has invested 0.81% in the stock. Deprince Race & Zollo Inc, a Florida-based fund reported 433,676 shares.

More notable recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: Nasdaq.com which released: “Innophos (IPHS) Earnings Miss Estimates in Q3, Sales Rise Y/Y – Nasdaq” on November 05, 2018, also Seekingalpha.com with their article: “Innophos – 2022 Targets Look Too Ambitious After A Softer 2017 – Seeking Alpha” published on April 06, 2017, Seekingalpha.com published: “Innophos Holdings, Inc. (IPHS) CEO Kim Ann Mink on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” on July 30, 2018. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) were released by: Businesswire.com and their article: “Innophos Appoints Eugenia Erlij as Vice President, Marketing – Business Wire” published on February 20, 2018 as well as Businesswire.com‘s news article titled: “Innophos to Host First-Quarter 2018 Financial Results Conference Call on May 1 – Business Wire” with publication date: April 18, 2018.

Innophos Holdings, Inc. (NASDAQ:IPHS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.